A Day Up For GH Research PLC

Tue, Nov 22, 2022 at 07:25 PM

GH Research PLC (GHRS:NASDAQ) jumped higher at $12.51, representing a gain of 25.9%. On Tue, Nov 22, 2022, GHRS:NASDAQ hit a New 2-Week High of $12.51. The stock got featured on our News Catalysts scanner on Thu, Nov 10, 2022 at 07:54 AM in the 'INVESTOR UPDATE' category. From Wed, Nov 09, 2022, the stock recorded 55.56% Up Days and 70.00% Green Days

About GH Research PLC (GHRS:NASDAQ)

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Top 10 Gainers:

Palisade Bio Inc. (PALI:NASDAQ), 81.08%
Motorsport Games Inc. (MSGM:NASDAQ), 51.11%
FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 47.57%
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 34.31%
XL Group Ltd (XL:NYSE), 30.91%
Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 30%
Digital Brands Group Inc. (DBGI:NASDAQ), 28.53%
Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
Draganfly Inc. (DPRO:NASDAQ), 27.19%
GH Research PLC (GHRS:NASDAQ), 25.86%